Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.265    -0.005 (-1.85%)
Bid:
0.25
Ask:
0.28
Spread: 0.03 (12.00%)
Market Cap: £15.36m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading Update

16 Apr 2019 07:00

RNS Number : 2660W
CAP-XX Limited
16 April 2019
 

16 April 2019

 

CAP-XX Limited

("CAP-XX" or the "Company")

Trading Update

CAP-XX Limited, a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems, today announces a trading update in respect of its recent activities.

 

CAP-XX to open European office

 

Over the last few quarters, CAP-XX has achieved success in securing orders for the supply of supercapacitors to Tier-1 component suppliers to the global automotive industry. In order to strengthen its relationships in this increasingly important segment, the Company has appointed Marco Ranalli to lead CAP-XX's European business strategy serving the specialist demands of the automotive industry as well as the internet of things (IoT). Mr Ranalli was most recently Global Director of Gentherm's Battery Systems Business Unit and has over 20 years' experience in the automotive markets. Gentherm is a NASDAQ listed automotive supply company. Mr Ranalli will also evaluate the potential benefits of establishing a local engineering and new business centre in Germany and in the meantime will work alongside CAP-XX's European distributor network to develop supercapacitor solutions to meet the specific demands of the automotive sector.

 

Pipeline and licensing activity

 

CAP-XX is continuing to receive record interest in its expanded range of supercapacitors, notably for applications relating to the IoT. The range of markets where enquiries are at record levels include Automotive (non power train). Enquiries are also at a high level for customers in the IoT (Wireless, Track & Trace applications), and Smart Meter industries. There has been some softening in demand from manufacturers of Wearable Technologies. It is clear that the slowdown in vehicle demand has not affected demand for the Company's products in the informatics and other low energy automotive applications, although the time to market for developing large cells for vehicle motive power and storage applications has slowed, with the result that CAP-XX has rebalanced its immediate-term focus around small cell automotive applications. The Company's previously announced sales to Spire have not been followed up with new orders, as Spire has been impacted by trade tariffs into the US. Spire has repositioned its device from the sports leisure market to the professional medical market in order to sustain a higher price point.

 

CAP-XX's current licensees include Murata, AVX and TDK. The Company remains in active discussions with a small group of potential further licensees in addition to a similar number of discussions which are at a less advanced stage. Most of these potential licensees are international component makers and companies focused on the energy storage markets. It is not possible to be precise on the timing of securing additional licensees, although the Board believes that further progress will be made during this calendar year. In the meantime, CAP-XX continues to enjoy rising enquiry levels and views future licensing opportunities with increasing confidence.

 

Intellectual property

 

CAP-XX continues to vigorously defend its intellectual property (IP) which it believes to be the cornerstone of its position as the world leader in prismatic supercapacitors, as well as a world leader in the broader supercapacitor market. The level of IP infringement it suffers as a consequence of this has prompted the Company to dedicate the necessary resources to protect its position through litigation where necessary. The level and strength of CAP-XX's international licensees bears testament to this position and IP conflict resolution is an active source of new licensees whilst defence of the IP is a part of the Company's duty of care to its contracted licensees. The Company is currently in the process of litigation with two counterparties in the United States. The Board is aware that the litigation process in the US can be protracted. CAP-XX continues to provide for and monitor its costs in this area very closely and continually evaluates the benefits of its IP defence strategy as well as constantly reviewing the requirement to file additional patent infringement claims.

 

Outlook

 

In the Company's announcement of 6 March 2019, CAP-XX highlighted the importance of a series of customer visits in relation to understanding certain customers' order positions and how these will translate into shorter term sales revenue. The Company is still in the process of conducting a number of these customer visits and the Board will provide an update on trading in respect of the anticipated overall outcome for the full year ending 30 June 2019 in due course.

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

 

Allenby Capital (Nominated Adviser and Broker

David Hart / Alex Brearley +44 (0) 20 3328 5656

 

 

More information is available at www.cap-xx.com

 

Notes to Editors:

 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, prismatic supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGUPGCUPBGMA
Date   Source Headline
2nd Feb 20267:00 amRNSInterim Results
23rd Jan 20267:00 amRNSNotice of Interim Results & Investor Presentation
19th Dec 202510:13 amRNSReceipt of R&D tax credit
19th Dec 202510:13 amRNSReceipt of R&D tax credit
10th Dec 20252:16 pmRNSHolding(s) in Company
28th Nov 20255:00 pmRNSTotal Voting Rights
28th Nov 202510:13 amRNSResult of AGM
14th Nov 20257:00 amRNSIssue of Shares and Director/PDMR Shareholding
10th Nov 20257:00 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSFinal results and notice of AGM
30th Oct 20251:02 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSImplementation of Warehouse Management System
10th Sep 202511:48 amRNSHolding(s) in Company
7th Aug 20257:00 amRNSHolding(s) in Company
5th Aug 20257:00 amRNS-RDesign Win with Global Semiconductor Manufacturer
31st Jul 20255:00 pmRNSTotal Voting Rights
25th Jul 20257:00 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSUpdate re. collaboration with SCHURTER
2nd Jul 20257:00 amRNSHolding(s) in Company
1st Jul 20257:29 amRNSIssue of Shares and Director/PDMR Shareholdings
30th Jun 20257:00 amRNSGlobal Distribution Agreement with RS Group plc
9th Jun 20257:00 amRNSBusiness Update and Appointment of Interim CFO
30th May 202510:32 amRNS-RUpdated website
13th May 202511:31 amRNS-RDesign Win with Multinational Conglomerate
30th Apr 20251:57 pmRNSChange of Auditor
26th Mar 20257:00 amRNSGrant of share options
19th Mar 20257:00 amRNSChange of Board Structure and Grant of Options
18th Mar 20259:35 amRNSGlobal Distribution Agreement with Premier Farnell
12th Mar 20252:43 pmRNSTechnology Cooperation Agreement with SCHURTER
7th Mar 20257:00 amRNSMaster Distribution Agreement with Waldom
17th Feb 20257:00 amRNSHalf-year Results
11th Feb 20257:00 amRNSNotice of Interim Results & Investor Presentation
31st Jan 20255:00 pmRNSTotal Voting Rights
21st Jan 20254:27 pmRNSIssue of Shares and Director/PDMR Shareholding
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
17th Jan 20257:00 amRNS-RDistribution agreement with JM Elektronik
15th Jan 20257:00 amRNSFirst shipment to SCHURTER AG
13th Jan 202511:29 amRNSResult of AGM
7th Jan 20257:00 amRNSManagement and board changes
31st Dec 20241:00 pmRNSTotal Voting Rights
9th Dec 202410:19 amRNSNotice of AGM
5th Dec 20248:18 amRNSResult of General Meeting
29th Nov 20245:00 pmRNSTotal Voting Rights
29th Nov 20249:57 amRNSDirectors' Subscription
29th Nov 20247:00 amRNSAudited results for the year ended 30 June 2024
5th Nov 20247:00 amRNSResult of Retail Offer, Notice of GM and TVR
1st Nov 20247:00 amRNSResult of Placing
31st Oct 20244:40 pmRNSRetailBook Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.